BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer]. 1988

H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010751 Phosphopyruvate Hydratase A hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity. Enolase,Neuron-Specific Enolase,2-Phospho-D-Glycerate Hydro-Lyase,2-Phospho-D-Glycerate Hydrolase,2-Phosphoglycerate Dehydratase,Enolase 2,Enolase 3,Muscle-Specific Enolase,Nervous System-Specific Enolase,Non-Neuronal Enolase,alpha-Enolase,beta-Enolase,gamma-Enolase,2 Phospho D Glycerate Hydro Lyase,2 Phospho D Glycerate Hydrolase,2 Phosphoglycerate Dehydratase,Dehydratase, 2-Phosphoglycerate,Enolase, Muscle-Specific,Enolase, Nervous System-Specific,Enolase, Neuron-Specific,Enolase, Non-Neuronal,Hydratase, Phosphopyruvate,Hydro-Lyase, 2-Phospho-D-Glycerate,Muscle Specific Enolase,Nervous System Specific Enolase,Neuron Specific Enolase,Non Neuronal Enolase,System-Specific Enolase, Nervous,alpha Enolase,beta Enolase,gamma Enolase
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
June 1992, Nihon Kyobu Shikkan Gakkai zasshi,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
October 1994, British journal of cancer,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
August 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].
January 2002, Pneumonologia i alergologia polska,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
April 1988, Rinsho byori. The Japanese journal of clinical pathology,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
September 1992, British journal of cancer,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
January 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum].
January 1995, Pneumonologia i alergologia polska,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
[Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
February 1987, Radioisotopes,
H Moriya, and S Hisa, and T Satoh, and S Suzuki, and K Kimura, and Y Higuchi, and K Hoshi
Neuron specific enolase in small cell lung cancer. Clinical and biochemical evaluation.
February 1999, Danish medical bulletin,
Copied contents to your clipboard!